伊伐布雷定與心血管系統(tǒng)疾病doc(參考版)
2025-07-20 16:49本頁面
【正文】 參考文獻(xiàn)：1. Fox K,Ford I,Steg PG,et rate as a prognostic risk factor in patients with coronary artery disease and leftventricular systolic dysfunction (BEAUTIFUL):a subgroup analysis of a randomised controlled trial[J].Lancet,2008,372(9641):817 821.2. Michels G,Brandt MC,Zagidullin N,et evidence for calcium conductance of hyperpolarizationactivated cyclic nucleotidegated channels and human native If at physiological calcium concentrations [J].Cardiovasc Res,2008,78(3):466475.3. Chandler NJ,Greener ID,Tellez JO,et architecture of the human sinus node:insights into the function of the cardiac pacemaker [J].Circulation,2009, 119(12):15621575.4. Di Francesco inhibition:a novel mechanism of action[J].Eur Heart J,2003,24 (5):G19G25.5. Manz M,Reuter M,Lauck G,et single intravenous dose of ivabradine,a novel I(f) inhibitor,lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction[J]. Cardiology,2003,100(3):149155.6. Savelieva I,Camm (f) inhibition with ivabradine: electrophysiolo gical effects and safety[J].Drug Saf,2008,31(2):95107.7. European Public Assessment Report(EPAR):Scientific discussion for Procoralan. London:EMEA,2005.8. Macher JP,Levy of ivabradine, a novel antianginal agent,on driving performance: A randomized, doubleblind, placebocontrolled trial in healthy volunteers[J].Clin Drug Invest,2009,29(5):339348.9. Diaz A,Bourassa MG,Guertin MC,et prognostic value of resting heart rate in patients with suspected or proven coronary artery disease[J].Eur Heart J,2005,26(10):967974.10. Custodis F,Baumhakel M,Sehlimmer N,et rate reduction by ivabradine reduces oxidative stress,improves endothelial function,and prevents atherosclerosis in apolipoprotein Edeficient mice[J]. Circulation,2008,117(18): 23772387.11. Triggle the economists:a decrease in heart rate improves not only cardiac but also endothelial function[J].Br J Pharmacol,2008, 154(4):727728．12. Alberto DR,Gabriela BP,Pedro AG. Increased heart rate and atherosclerosis: Potential implications of ivabradine therapy[J]. World J Cardiol,2011,3(4): 101 104.13. Skalidis EI, Hamilos MI, Chlouverakis G,et a1. Ivabradine improves coronary flow reserve in patients with stable coronary artery disease[J]. Atherosclerosis, 2011,215 (1):160165.14
公司管理相關(guān)推薦
鄂ICP備17016276號(hào)-1